top of page

Zeng Lab

IISG 2.jpg

IISG (A*STAR SPIN-OFF)
PRL3zumab New Cancer Therapy

cancer background.PNG

PRL-3 Phosphatase & Cancer Therapy

cancer background.PNG

News

ASTAR research 17 Dec 25.png

17 Dec 2025

A*STAR RESEARCH

Sprouting hope to save sight

ASTAR research 30 Oct 25.png

30 Oct 2025

A*STAR RESEARCH

Broad new hope for late-stage IV cancer

14 Jul 2025

A*STAR News

Singapore-Developed Cancer Drug Shows Promise As Treatment For Blindness

Astar - Eye News.png

Straits times 140725.jpg

14 Jul 2025

THE STRAITS TIMES

Locally Developed Cancer Drug Shows Promise As Treatment for Blindness; Trial To Start Soon

14 Jul 2025

联合早报 (LIANHE ZAOBAO)

本地抗癌药新用途有望治疗两大致盲疾病 (Locally developed anti-cancer drug finds new application, potentially treating two major blinding diseases)

Lian He zhao bao 140725 (2).PNG.jpg

Press release 140725_edited.jpg

14 Jul 2025

Press Release

Singapore-Developed Cancer Drug Shows Promise as Treatment for Blindness

27 May 2025

A*STAR News

Phase II Trial Completed – Singapore’s New Anti-Cancer Drug One Step Away from Market

ASTAR news.PNG

Lian He zhao bao.PNG

27 May 2025

联合早报 (LIANHE ZAOBAO)

完成二期试验本地抗癌新药离面市仅一步 (After Completing The Phase II Clinical Trial, The Local New Anti-Cancer Drug Is Only One Step Away From Being Launched On The Market)

09 May 2025

Press Release

SINGAPORE-DEVELOPED CANCER IMMUNOTHERAPY OFFERS NEW HOPE FOR LATE-STAGE CANCER PATIENTS PRL3-zumab demonstrates safety and clinical benefit in FDA-approved Phase II trial across multiple cancer types

Press release 090525.PNG

GEN (4).png

09 May 2025

Genetic Engineering & Biotechnology News

Intra-ImmuSG Focuses on Intracellular Targets for Cancer Immunotherapy

16 Jan 2025

A*STAR NEWS

Unlocking New Therapeutic Pathways: PRL1 and PRL3 in Tumour Growth and Cancer Immunotherapy

Astar - PRL1 & PRL3.png

ASTAR research.png

04 Mar 2024

A*STAR Research

Targeted Therapy Sparks Childhood Cancer Hope

bottom of page